{
    "2018-02-28": [
        [
            {
                "time": "",
                "original_text": "医疗保健：以业绩为导向 荐8股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "业绩",
                        "导向",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 国泰君安医药行业3月策略暨年报业绩前瞻专题：聚焦高景气细分领域",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "医药行业",
                        "3月策略",
                        "年报业绩",
                        "高景气",
                        "细分领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药:业绩符合预期,大临床与BE业务持续高增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩",
                        "预期",
                        "大临床",
                        "BE业务",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}